tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Massaro, 346 are a BUY (86.07%), 45 are a HOLD (11.19%), 11 are a SELL (2.74%).
Analyst Mark Massaro, currently employed at BTIG, carries an average stock price target met ratio of 50.59% that have a potential upside of 31.29% achieved within 182 days.
Mark Massaro’s has documented 790 price targets and ratings displayed on 46 stocks. The coverage is on Healthcare, Technology, Industrials sectors.
Most recent stock forecast was given on EXAS, EXACT Sciences at 24-Mar-2026.
Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for PSNL (PERSONALIS) at 8/8/2024. The price target of $5.5 was fulfilled within 8 days with a profit of $2.07 (60.35%) receiving and performance score of 75.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Oct-2020
$22
$9.59 (77.28%)
$19
1 months 24 days ago
(06-Feb-2026)
9/14 (64.29%)
$6.23 (39.51%)
146
Hold Since 09-Sep-2020
$16
$3.59 (28.93%)
$11
4 months 19 days ago
(11-Nov-2025)
10/14 (71.43%)
$1.47 (10.12%)
554
Buy Since 03-Aug-2023
$20
$7.59 (61.16%)
$10
4 months 24 days ago
(06-Nov-2025)
8/8 (100%)
$4.44 (28.53%)
204
Buy Since 08-May-2023
$20
$7.59 (61.16%)
$15
5 months 15 days ago
(15-Oct-2025)
16/16 (100%)
$2.89 (16.89%)
356
Buy Since 21-Mar-2025
$10
$-2.41 (-19.42%)
$9
10 months 28 days ago
(02-May-2025)
5/7 (71.43%)
$0.16 (1.63%)
78
Which stock is Mark Massaro is most bullish on?
Which stock is Mark Massaro is most reserved on?
What Year was the first public recommendation made by Mark Massaro?
